-
Phase III COVID-19 antibody trials initiated in Americas
europeanpharmaceuticalreview
July 10, 2020
Simultaneous Phase III trials evaluating Regeneron’s REGN-COV2 antibody as both a prophylactic and a treatment have begun in US and some South American locations.
-
Busy Month of Approvals: A Review of Oncology Drugs Approved in May in China and world market
PharmaSources/Xiaobin
July 03, 2020
The first half of 2020 will pass soon. Although foreign countries are still under the shadow of the COVID-19 pandemic, China’s situation is gradually stabilizing and improving through the concerted efforts of all to fight the pandemic.
-
Antibody levels in recovered COVID-19 patients decline quickly: research
expresspharma
June 23, 2020
The research highlights the risks of using COVID-19 ‘immunity passports’ and supports the prolonged use of public health interventions such as social distancing and isolating high-risk groups, researchers said.
-
Researchers identify potent antibody cocktail to treat COVID-19
worldpharmanews
June 19, 2020
Researchers at the University of Maryland School of Medicine (UMSOM) evaluated several human antibodies to determine the most potent combination to be mixed in a cocktail and used as a promising anti-viral therapy against the virus that causes COVID-19.
-
Scientists discover new super-potent human antibodies that can protect against COVID-19
expresspharma
June 17, 2020
These antibodies may also be used to provide temporary, vaccine-like protection against SARS-CoV-2 infection for healthcare workers, elderly people, and others who respond poorly to traditional vaccines.
-
AstraZeneca licences Covid-19 antibody candidates from VU
pharmaceutical-technology
June 10, 2020
AstraZeneca has licensed six coronavirus-neutralising antibody candidates from Vanderbilt University (VU) in the US, with plans to advance two into clinical development to prevent and treat Covid-19.
-
Just - Evotec Biologics, ABL Enter Clinical Supply Pact
contractpharma
June 10, 2020
Just - Evotec Biologics to design a manufacturing process for the production of Phase I cGMP clinical supply of a broadly neutralizing antibody against HIV.
-
SwiftScale Manufactures COVID-19 Antibody Candidate
contractpharma
June 10, 2020
Uses rapid biologics manufacturing technology to accelerate development of treatments.
-
AbbVie and partners to develop monoclonal antibody against Covid-19
pharmaceutical-technology
June 09, 2020
AbbVie has partnered with Harbour BioMed (HBM), Utrecht University (UU) and Erasmus Medical Center (EMC) to develop a monoclonal antibody therapeutic for the prevention and treatment of Covid-19.
-
Shanghai Junshi Biosciences starts human tests for coronavirus antibody drug
expresspharma
June 08, 2020
The experimental drug, JS016, is also expected to begin human study in the US in the second quarter of this year, through collaboration with Eli Lilly and Co.